Nava Health MD, Inc. (NAVA)

Nava Health MD was planning to go public, but the IPO was withdrawn on Mar 24, 2023.

IPO Price

$6.00

Shares Offered

1,350,000

Deal Size

$8.10M

Nava Health MD Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	9.27	6.66	4.84
Revenue Growth (YoY)	-	37.44%	-
Cost of Revenue	-	3.25	2.19
Gross Profit	4.86	3.41	2.66
Selling, General & Admin	-	4.52	3.21
Other Operating Expenses	0	0.19	0.11
Operating Expenses	-	4.72	3.32
Operating Income	-1.54	-1.31	-0.66
Interest Expense / Income	0.07	0.08	0.12
Other Expense / Income	-0.58	-1.08	-1.26
Pretax Income	-1.04	-0.31	0.47
Net Income	-1.04	-0.31	0.47
Free Cash Flow	-1.77	-1.5	-0.34
Gross Margin	52.40%	51.16%	54.87%
Operating Margin	-16.62%	-19.68%	-13.71%
Profit Margin	-11.16%	-4.61%	9.77%
Free Cash Flow Margin	-19.08%	-22.54%	-6.94%
EBITDA	-0.87	-0.18	0.62
EBITDA Margin	-9.34%	-2.67%	12.76%
Depreciation & Amortization	0.1	0.05	0.03
EBIT	-0.96	-0.23	0.59
EBIT Margin	-10.39%	-3.44%	12.25%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).